AML patients with aberrant MMP7 or MMP15 expression have a substantially poor prognosis, and this finding raises the possibility that MMP7 and MMP15 are potential prognostic markers and therapeutic targets for AML [50]. The gene discussed is MMP15; the disease is acute myeloid leukemia.